Spruce Biosciences, Inc.
SPRB and SPRBD • NASDAQ
Spruce Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Javier Szwarcberg, with a market cap of $90.6M.
Market Cap$90.6M
Employees22.0
CEOJavier Szwarcberg
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
SPR
Spruce Biosciences, Inc. FAQ
Common questions about Spruce Biosciences, Inc.
Spruce Biosciences, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026.
Spruce Biosciences, Inc. has approximately 22 employees.